ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,940Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 580

$1.56M Total Retail Price of All Prescriptions

Rank: 1 out of 580

453 Patients Receiving at Least One Drug in Part D
67% Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Utah
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

14% of this provider’s 453 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 453 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Utah
LEVOTHYROXINE SODIUM 781 427 106 1 1
WARFARIN SODIUM 741 525 42 2 14
OMEPRAZOLE 728 229 100 3 2
FUROSEMIDE 710 458 76 4 9
POTASSIUM CHLORIDE 661 384 70 5 15
ATORVASTATIN CALCIUM 553 358 70 6 8
CYMBALTA 524 309 41 7 32
HYDROCODONE-ACETAMINOPHEN 512 352 89 S3 8 5
POLYETHYLENE GLYCOL 3350 481 121 75 9 55
LISINOPRIL 457 300 64 10 4
GABAPENTIN 418 149 56 11 11
LANTUS 409 186 51 12 41
QUETIAPINE FUMARATE 375 285 43 A 13 43
SIMVASTATIN 363 194 59 14 3
TRAZODONE HCL 349 148 63 15 20
CITALOPRAM HBR 341 161 56 16 13
NAMENDA 330 255 30 17 50
CLONAZEPAM 319 102 42 B 18 29
SERTRALINE HCL 310 175 34 19 21
OLANZAPINE 299 74 30 A 20 84
DIVALPROEX SODIUM ER 298 94 30 21 122
LORAZEPAM 280 121 96 B 22 25
NOVOLOG 275 114 45 23 111
METFORMIN HCL 275 170 42 23 6
RISPERIDONE 269 124 29 A 25 63
DONEPEZIL HCL 238 206 33 26 45
TRAMADOL HCL 234 122 48 27 16
LEVOFLOXACIN 223 119 106 28 107
BACLOFEN 223 78 28 28 103
DIVALPROEX SODIUM 222 56 34 30 85
BENZTROPINE MESYLATE 214 26 25 R 31 116
LAMOTRIGINE 214 24 20 31 90
OXYBUTYNIN CHLORIDE ER 214 142 23 31 101
METOPROLOL TARTRATE 183 118 31 34 28
MELOXICAM 177 100 25 35 26
LEVETIRACETAM 171 12 14 36 124
NITROFURANTOIN MONO-MACRO 171 106 98 36 163
ABILIFY 168 15 12 A 38 97
AMLODIPINE BESYLATE 165 149 27 39 7
TAMSULOSIN HCL 154 79 28 40 24
MIRTAZAPINE 148 108 29 41 79
LYRICA 141 44 15 42 67
CARVEDILOL 134 74 22 43 34
ROPINIROLE HCL 131 40 18 44 83
FLUOXETINE HCL 128 49 20 45 27
LACTULOSE 127 36 14 46 108
CEPHALEXIN 126 62 66 47 96
HYDROCHLOROTHIAZIDE 125 80 17 48 12
ALENDRONATE SODIUM 124 65 19 49 30
ALLOPURINOL 122 84 15 50 38
FLUTICASONE PROPIONATE 121 39 22 51 31
PANTOPRAZOLE SODIUM 121 80 16 51 52
AMOXICILLIN 119 23 54 53 102
RISPERDAL CONSTA 118 <11 <11 A 54 187
TIZANIDINE HCL 115 17 11 55 89
SPIRIVA 112 70 23 56 88
HUMALOG 110 72 21 57 148
PROMETHAZINE HCL 107 26 33 R 58 121
RANITIDINE HCL 106 33 15 59 58
FINASTERIDE 101 80 14 60 92
FORTICAL 100 11 15 61 198
DIOVAN 99 <11 <11 62 86
TOPIRAMATE 98 <11 <11 63 117
METOCLOPRAMIDE HCL 93 41 11 64 170
ADVAIR DISKUS 89 45 24 65 66
PHENOBARBITAL 89 <11 <11 R 65 202
NYSTATIN 88 25 39 67 159
METOPROLOL SUCCINATE 88 68 15 67 22
CLORAZEPATE DIPOTASSIUM 85 0 11 B 69 151
NITROFURANTOIN* 83 37 20 70 179
HALOPERIDOL 82 46 11 A 71 164
OXYCODONE HCL 80 32 15 S2 72 35
PHENYTOIN SODIUM EXTENDED 79 <11 <11 73 156
TRIAMCINOLONE ACETONIDE 79 38 38 73 137
CARBIDOPA-LEVODOPA 78 52 11 75 152
CLOPIDOGREL 75 33 16 76 39
PIOGLITAZONE HCL 75 <11 <11 R 76 78
CALCITONIN-SALMON 75 <11 13 76 209
FAMOTIDINE* 74 <11 <11 79 126
OXYCODONE-ACETAMINOPHEN 73 46 24 S2 80 64
VIMPAT 73 <11 <11 80 212
MORPHINE SULFATE ER 72 <11 <11 S2 82 60
ZIPRASIDONE HCL 72 <11 <11 A 82 142
OXCARBAZEPINE 71 <11 <11 84 165
PRAVASTATIN SODIUM 71 52 12 84 23
PRIMIDONE 70 <11 <11 86 213
CLOZAPINE 69 <11 <11 A 87 215
AMOX TR-POTASSIUM CLAVULANATE 69 27 42 87 119
NYSTOP 68 17 28 89 217
PREVACID 63 <11 <11 90 222
ESCITALOPRAM OXALATE 61 44 12 91 57
OXYCODONE HCL-ACETAMINOPHEN 61 <11 <11 S2 91 46
ALBUTEROL SULFATE 60 45 24 93 181
OXYBUTYNIN CHLORIDE 60 44 15 93 95
ZOLPIDEM TARTRATE 60 28 15 93 10
SYNTHROID 59 <11 <11 96 54
ZONISAMIDE 58 <11 <11 97 181
VALPROIC ACID* 58 <11 <11 97 154
FENTANYL 57 <11 <11 S2 99 68
CELEBREX 57 <11 <11 99 47
BUSPIRONE HCL 56 <11 <11 101 135
CIPROFLOXACIN HCL 55 38 42 102 69
LIDOCAINE HCL* 55 32 38 102 234
SPIRONOLACTONE 54 32 11 104 80
CEFTRIAXONE* 53 35 35 105 240
IBUPROFEN 52 14 20 106 42
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 33 31 106 131
ZETIA 52 <11 <11 106 114
VENLAFAXINE HCL ER 52 <11 <11 106 77
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.